Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd

Bullboard Posts

Post by WarrantOfficeron Nov 18, 2020 9:12pm

841 Views

Post# 31928158

Investors Mislead

To withdrawl a corporate presentation and inform present / future investors not to make any relevance to it is alarming, specifically to those whom have already invested based on this presentation. As for the C60 project claiming they have exclusive rights to one of the worlds rarest pharamceutical minerals and then claim that they have no rights to it at all is nothing short of fraudulent.

Bullboard Posts

Here are three global stocks you should watch